Akbulut, D. Et Al. 2021. Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis. MODERN PATHOLOGY , vol.34, no.SUPPL 2 , 796-797.

Akbulut, D., Yüksel, S., Kircali, E., Aktaş, B. Y., Kaygusuz, G., Saglam, A., ... Soylemezoglu, F.(2021). Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis. MODERN PATHOLOGY , vol.34, no.SUPPL 2, 796-797.

Akbulut, Dilara Et Al. "Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis," MODERN PATHOLOGY , vol.34, no.SUPPL 2, 796-797, 2021

Akbulut, Dilara Et Al. "Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis." MODERN PATHOLOGY , vol.34, no.SUPPL 2, pp.796-797, 2021

Akbulut, D. Et Al. (2021) . "Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis." MODERN PATHOLOGY , vol.34, no.SUPPL 2, pp.796-797.

@article{article, author={Dilara Akbulut Et Al. }, title={Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis}, journal={MODERN PATHOLOGY}, year=2021, pages={796-797} }